BBI Life Sciences Corporation reported audited consolidated capital expenditure results for the year ended December 31, 2016. For the year, the company reported purchase of property, plant and equipment was RMB 128,894,000 compared to RMB 56,352,000 a year ago. Acquisition of intangible assets was RMB 16,000 compared to RMB 1,996,000 a year ago.